UK Cannabis

The Food Standards Agency (FSA) will recommend a first set of three CBD product applications to ministers in spring/summer 2025, the agency said in its latest report. A recommendation will be made following an eight-week public consultation launching in early 2025. "Three applications for CBD (>...

Data from Benzinga Pro shows High Tide Inc. (NASDAQ:HITI) shares experienced a significant surge, gaining over 21% in the last two trading sessions, closing at $3.47 on Monday, December 2. This positive performance was reflected in a trading volume of 2,396,045 shares and a market capitalization of...

The UK government announced changes to ease restrictions on hemp farming, but it did not make it clear if it plans to raise the THC limit for industrial hemp from 0.2% to 0.3%, writes Hemp Today. Under the new rules, starting in the 2025 growing season, licensed growers will be allowed to plant...

Six years after the United Kingdom legalized medical marijuana, families struggling to obtain life-saving medicine through the National Health Service (NHS) returned to Westminster on Tuesday, demanding change. They displayed photos of their loved ones who experienced significant improvement with...

As many as 90%of illegal cannabis samples tested in the UK contained contaminants, including mold, yeast, lead, E.coli or salmonella, according to new research. This report combines data from several sources, including laboratory analyses of 60 illegal cannabis samples seized by law enforcement in...

Drug-related deaths in England and Wales have surged to their highest level since 1993, according to the latest figures from the Office for National Statistics (ONS). An alarming 5,448 fatalities were registered in 2023 alone, marking an 11% increase from the previous year. Cocaine-related deaths...

Allowing medical marijuana to be prescribed on the National Health Service (NHS) for chronic pain could save the national healthcare provider nearly £4 billion annually ($5.19 billion), new research reveals. The independent analysis of the economic case for prescribing medical cannabis on the NHS...

One of the UK’s fastest-growing medical marijuana providers, Releaf, confirmed Tuesday it has partnered with domestic producer of medical cannabis, Glass Pharms. Under the partnership, Glass Pharms will provide Releaf with 145kg (320 pounds) of high-quality medical-grade cannabis. “This...

The Cannabis Industry Council (CIC) has published a good practice guide for prescription cannabis clinics in the United Kingdom. The guidance contains 10 principles of good practice and five specific policies for clinics to implement. "The Cannabis Industry Council believes that prescription...

“Commercial success is a mark of failure for a graffiti artist. We're not supposed to be embraced in that way.” Banksy A UK cannabis dealer who laundered his illegal earnings through artworks by the elusive British street artist Banksy has been sentenced to three years in prison....

Over the past several years, Europe has become more open-minded about medical and recreational marijuana. Here are some of the latest cannabis developments from Malta, Germany, and the United Kingdom. Malta: Officials Will Confiscate HHC Products Malta officials confirmed recently in a press...

New Polish And Portuguese Hemp Partnership Hemp&Health (WSE: HMP), a Polish medical cannabis company, agreed to acquire a 5% stake in the Portuguese company Hibisco Discreto, which owns the Voyager Genetics brand, reported Business of Cannabis. The shares were bought for €20,000 ($22,065)....

The United Kingdom could generate between $4.38 billion and $12.6 billion annually in tax revenue by legalizing and regulating cannabis for adult use, according to a new report by CLEAR, a cannabis reform advocacy group. The paper lays out a detailed framework for the UK’s potential cannabis...

InterCure Ltd. (NASDAQ:INCR) has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates. The company reported revenues of 126 million NIS ($33.97 million), surpassing the estimated 121 million NIS. ...

The London-listed cannabis-focused pharma company Celadon Pharmaceuticals Plc (AIM: CEL) raised £1.05 million ($1.37 million) by selling 2.63 million new ordinary shares at 40 pence per share. This price is about 23.8% lower than the previous day's share price of 52.5 pence. The discounted...